Inexium



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 13.5%
Gastrooesophageal Reflux Disease 12.2%
Product Used For Unknown Indication 9.5%
Pain 8.1%
Gastric Ulcer 6.1%
Cord Blood Transplant Therapy 5.4%
Pyrexia 5.4%
Prophylaxis 4.7%
Abdominal Pain Upper 4.1%
Depression 3.7%
Haemolytic Uraemic Syndrome 3.4%
Lymphoma 3.4%
Antibiotic Therapy 3.0%
Rheumatoid Arthritis 3.0%
Atrial Fibrillation 2.7%
Anxiety 2.4%
Cardiac Failure 2.4%
Chronic Obstructive Pulmonary Disease 2.4%
Cytomegalovirus Infection 2.4%
Gout 2.4%
Thrombocytopenia 14.1%
Toxic Skin Eruption 12.5%
Neutropenia 10.2%
Vomiting 8.6%
Hyponatraemia 6.3%
Renal Failure Acute 5.5%
Pancytopenia 4.7%
Transaminases Increased 4.7%
Hepatocellular Injury 3.9%
Malaise 3.1%
Pruritus 3.1%
Rhabdomyolysis 3.1%
Sepsis 3.1%
Tubulointerstitial Nephritis 3.1%
Drug Reaction With Eosinophilia And Systemic Symptoms 2.3%
Hypomagnesaemia 2.3%
Leukopenia 2.3%
Lung Disorder 2.3%
Off Label Use 2.3%
Paraparesis 2.3%
Secondary
Product Used For Unknown Indication 68.9%
Gastrooesophageal Reflux Disease 3.5%
Hypertension 3.2%
Drug Use For Unknown Indication 3.1%
Prophylaxis 2.2%
Hiatus Hernia 1.8%
Foetal Exposure During Pregnancy 1.8%
Maternal Exposure Timing Unspecified 1.8%
Gastric Ulcer 1.7%
Pyrexia 1.5%
Pain 1.4%
Barrett's Oesophagus 1.3%
Rheumatoid Arthritis 1.3%
Drug Exposure Via Mother 1.2%
Cytomegalovirus Infection 1.1%
Depression 1.0%
Diabetes Mellitus 0.9%
Cough 0.8%
Infection 0.8%
Nausea 0.7%
Thrombocytopenia 15.6%
Vomiting 8.5%
Toxic Skin Eruption 6.6%
Hyponatraemia 6.1%
Toxic Epidermal Necrolysis 5.7%
Agranulocytosis 5.2%
Renal Failure Acute 5.2%
Drug Reaction With Eosinophilia And Systemic Symptoms 4.7%
Neutropenia 4.7%
Transaminases Increased 4.2%
Leukopenia 3.8%
Pyrexia 3.8%
Vision Blurred 3.8%
Hepatocellular Injury 3.3%
Hypertriglyceridaemia 3.3%
Pruritus 3.3%
Rash 3.3%
Somnolence 3.3%
Cholestasis 2.8%
Foetal Growth Restriction 2.8%
Concomitant
Product Used For Unknown Indication 40.5%
Drug Use For Unknown Indication 10.9%
Hypertension 6.5%
Rheumatoid Arthritis 5.5%
Pain 4.2%
Atrial Fibrillation 3.8%
Prophylaxis 3.1%
Hepatitis C 2.7%
Thrombosis Prophylaxis 2.5%
Epilepsy 2.2%
Premedication 2.2%
Anxiety 2.1%
Hiv Infection 2.0%
Gastrooesophageal Reflux Disease 1.9%
Urinary Tract Infection 1.7%
Depression 1.7%
Ankylosing Spondylitis 1.7%
Crohn's Disease 1.7%
Plasma Cell Myeloma 1.6%
Type 2 Diabetes Mellitus 1.6%
Vomiting 10.6%
Renal Failure Acute 9.2%
Thrombocytopenia 8.9%
Renal Failure 6.8%
Pancytopenia 4.9%
Hepatocellular Injury 4.6%
Pulmonary Embolism 4.3%
Pyrexia 4.3%
Septic Shock 4.3%
Weight Decreased 4.3%
Hepatitis 4.1%
Rectal Haemorrhage 4.1%
Somnolence 4.1%
Toxic Skin Eruption 4.1%
Rash 3.8%
Sepsis 3.8%
International Normalised Ratio Increased 3.5%
Rhabdomyolysis 3.5%
Urticaria 3.5%
Tremor 3.3%
Interacting
Product Used For Unknown Indication 35.7%
Drug Use For Unknown Indication 10.0%
Depression 8.6%
Adrenal Insufficiency 4.3%
Arrhythmia Supraventricular 4.3%
Back Pain 4.3%
Insomnia 4.3%
Secondary Hypothyroidism 4.3%
Extrapyramidal Disorder 2.9%
Gastritis 2.9%
Hypertension 2.9%
Pyrexia 2.9%
Rheumatoid Arthritis 2.9%
Acute Coronary Syndrome 1.4%
Antiinflammatory Therapy 1.4%
Arthralgia 1.4%
Aspergillus Infection 1.4%
Brain Abscess 1.4%
Breast Cancer 1.4%
Coagulopathy 1.4%
Renal Failure Acute 26.3%
Drug Interaction 5.3%
Extrapyramidal Disorder 5.3%
General Physical Health Deterioration 5.3%
Hyponatraemia 5.3%
Metastases To Central Nervous System 5.3%
Overdose 5.3%
Prothrombin Time Ratio Decreased 5.3%
Status Epilepticus 5.3%
Suicidal Ideation 5.3%
Tachycardia 5.3%
Thrombosis In Device 5.3%
Toxicity To Various Agents 5.3%
Traumatic Haematoma 5.3%
Weight Decreased 5.3%